Krishna Institute of Medical Sciences Limited (NSE:KIMS)

India flag India · Delayed Price · Currency is INR
804.25
+14.50 (1.84%)
Jun 19, 2026, 3:29 PM IST
Market Cap321.81B +17.5%
Revenue (ttm)39.05B +28.6%
Net Income2.41B -37.2%
EPS6.03 -37.2%
Shares Out 400.14M
PE Ratio133.37
Forward PE75.35
Dividendn/a
Ex-Dividend Daten/a
Volume761,075
Open782.00
Previous Close789.75
Day's Range781.05 - 818.00
52-Week Range575.80 - 817.00
Beta0.19
AnalystsStrong Buy
Price Target825.63 (+2.66%)
Earnings DateAug 6, 2026

About NSE:KIMS

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers arthroscopy and shoulder, cardiology, cardiothoracic and cardiovascular, organ transplant, medical and surgical gastroenterology, hepatology, orthopaedic, neurology, neurosurgery, nephrology, urology, oncology, pediatric, neonatology, obstetrics and gynaecology, fertility, dental science, emergency and critical care, vascular, rehabilitation and physiotherapy services. It also provides pulmonology, ... [Read more]

Sector Healthcare
Founded 1973
Employees 5,264
Stock Exchange National Stock Exchange of India
Ticker Symbol KIMS
Full Company Profile

Financial Performance

In fiscal year 2026, NSE:KIMS's revenue was 39.05 billion, an increase of 28.65% compared to the previous year's 30.35 billion. Earnings were 2.41 billion, a decrease of -37.22%.

Financial Statements

Analyst Summary

According to 16 analysts, the average rating for KIMS stock is "Strong Buy." The 12-month stock price target is ₹825.63, which is an increase of 2.66% from the latest price.

Price Target
₹825.63
(2.66% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Krishna Institute of Medical Sciences Transcript: Q4 25/26

Revenue grew 35% YoY in Q4 FY26, but EBITDA margin declined due to new unit ramp-up and expansion. Mature units maintained strong margins, while new units narrowed losses; QIP will reduce debt and fund further growth. Insurance empanelment delays remain a key risk.

4 weeks ago - Transcripts

Krishna Institute of Medical Sciences Quarterly report: Q4 2026

Krishna Institute of Medical Sciences has published its Q4 2026 quarterly earnings report on May 18, 2026.

4 weeks ago - Filings

Krishna Institute of Medical Sciences Slides: Q4 2026

Krishna Institute of Medical Sciences has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 18, 2026.

4 weeks ago - Filings

Krishna Institute of Medical Sciences Transcript: Q3 25/26

Q3 FY26 saw record revenue above INR 1,000 crore, with strong growth in new hospitals but margin pressure from ramp-up costs. Debt has peaked and is expected to moderate as CapEx winds down, while break-even is targeted soon for new units.

4 months ago - Transcripts

Krishna Institute of Medical Sciences Quarterly report: Q3 2026

Krishna Institute of Medical Sciences has published its Q3 2026 quarterly earnings report on February 8, 2026.

4 months ago - Filings

Krishna Institute of Medical Sciences Slides: Q3 2026

Krishna Institute of Medical Sciences has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 8, 2026.

4 months ago - Filings

Krishna Institute of Medical Sciences Transcript: Q2 25/26

Q2 FY26 saw 23% revenue growth but EBITDA and EPS declined due to new hospital ramp-up costs. Margin expansion is expected as new units break even, with Andhra and Telangana clusters maintaining strong profitability. CGHS price hikes and insurance empanelment will support future margins.

7 months ago - Transcripts

Krishna Institute of Medical Sciences Quarterly report: Q2 2026

Krishna Institute of Medical Sciences has published its Q2 2026 quarterly earnings report on November 9, 2025.

7 months ago - Filings

Krishna Institute of Medical Sciences Slides: Q2 2026

Krishna Institute of Medical Sciences has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 9, 2025.

7 months ago - Filings

Krishna Institute of Medical Sciences Transcript: Q1 25/26

Revenue grew 26.8% YoY to INR 879 crore, with EBITDA at INR 200 crore and margin at 22.7%. New units in Thane, Bangalore, and Kerala are ramping up, with initial losses expected to neutralize within 12 months. Net debt stands at INR 2,020 crore, and ARPOB is projected to rise as new facilities mature.

11 months ago - Transcripts

Krishna Institute of Medical Sciences Quarterly report: Q1 2026

Krishna Institute of Medical Sciences has published its Q1 2026 quarterly earnings report on August 7, 2025.

11 months ago - Filings

Krishna Institute of Medical Sciences Slides: Q1 2026

Krishna Institute of Medical Sciences has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on August 7, 2025.

11 months ago - Filings